A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...
Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.
Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...
Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.